T. Rowe Price Associates’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-38,061
| Closed | -$2.24M | – | 3007 |
|
|
2023
Q4 | $2.24M | Sell |
38,061
-2,394,968
| -98% | -$141M | ﹤0.01% | 1469 |
|
|
2023
Q3 | $106M | Buy |
2,433,029
+655,450
| +37% | +$28.6M | 0.02% | 504 |
|
|
2023
Q2 | $64.2M | Buy |
1,777,579
+6,638
| +0.4% | +$240K | 0.01% | 628 |
|
|
2023
Q1 | $65.8M | Buy |
1,770,941
+354,213
| +25% | +$13.2M | 0.01% | 608 |
|
|
2022
Q4 | $64.2M | Buy |
1,416,728
+273,973
| +24% | +$12.4M | 0.01% | 594 |
|
|
2022
Q3 | $79.8M | Buy |
1,142,755
+91,225
| +9% | +$6.37M | 0.01% | 529 |
|
|
2022
Q2 | $70.6M | Sell |
1,051,530
-592,686
| -36% | -$39.8M | 0.01% | 766 |
|
|
2022
Q1 | $135M | Sell |
1,644,216
-530,583
| -24% | -$43.6M | 0.01% | 637 |
|
|
2021
Q4 | $319M | Buy |
2,174,799
+60,589
| +3% | +$8.89M | 0.03% | 440 |
|
|
2021
Q3 | $374M | Buy |
2,114,210
+192,431
| +10% | +$34M | 0.04% | 399 |
|
|
2021
Q2 | $310M | Buy |
1,921,779
+389,279
| +25% | +$62.9M | 0.03% | 450 |
|
|
2021
Q1 | $263M | Sell |
1,532,500
-26,916
| -2% | -$4.61M | 0.03% | 477 |
|
|
2020
Q4 | $343M | Buy |
1,559,416
+248,154
| +19% | +$54.5M | 0.04% | 403 |
|
|
2020
Q3 | $218M | Buy |
1,311,262
+2,410
| +0.2% | +$400K | 0.03% | 466 |
|
|
2020
Q2 | $149M | Buy |
1,308,852
+21,207
| +2% | +$2.42M | 0.02% | 537 |
|
|
2020
Q1 | $99M | Sell |
1,287,645
-97,734
| -7% | -$7.51M | 0.02% | 577 |
|
|
2019
Q4 | $179M | Buy |
1,385,379
+48,815
| +4% | +$6.29M | 0.02% | 505 |
|
|
2019
Q3 | $104M | Buy |
1,336,564
+130,420
| +11% | +$10.2M | 0.01% | 624 |
|
|
2019
Q2 | $124M | Buy |
1,206,144
+388,516
| +48% | +$40M | 0.02% | 591 |
|
|
2019
Q1 | $59.9M | Buy |
817,628
+488,468
| +148% | +$35.8M | 0.01% | 800 |
|
|
2018
Q4 | $14M | Buy |
329,160
+1,136
| +0.3% | +$48.2K | ﹤0.01% | 1250 |
|
|
2018
Q3 | $15.5M | Buy |
328,024
+115,559
| +54% | +$5.44M | ﹤0.01% | 1295 |
|
|
2018
Q2 | $10.5M | Buy |
212,465
+26,145
| +14% | +$1.29M | ﹤0.01% | 1337 |
|
|
2018
Q1 | $5.72M | Buy |
+186,320
| New | +$5.72M | ﹤0.01% | 1412 |
|